SEATTLE–(BUSINESS WIRE)– #earnings–NanoString reports Q4 and FY22 operating results. Click here to view original post
Icosavax, a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases and a vision of creating pan-respiratory vaccines for older […]
Seattle-based biotech Monod Bio has licensed a new luciferase technology (LuxSit), which is a de novo enzyme luciferase technology. The technology comes from the lab of Professor at the University of Washington School of Medicine […]
Newsweek and global research and data firm Statista announced the fourth-annual ranking of the 500 most responsible companies regarding ESG (environment, social and corporate governance) and corporate responsibility. Among the list is Seattle-based company Seagen. […]
The move puts brings Absci to a major European biotech hub. Click here to view original post
The surge in the incidence of neurological diseases, the prevalence of epilepsy and migraines in children, and the rise in the number of advanced product launches drive the growth of the global Pediatric Neurology Devices […]
Tom Schultz comes to Edifecs from Ability Networks, a health care billing platform where he worked as a senior vice president of sales. Click here to view original post
One dozen Democrat attorneys general are suing the FDA in federal court in the eastern district of Washington to remove all restrictions on mifepristone, a pill used in combination with another medicine to end early […]
EUGENE, Ore.–(BUSINESS WIRE)–Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announces the opening of a new 30,000ft2 cGMP facility in Eugene, OR […]
The state revenue forecast could undercut Measure 110 funding. Click here to view original post
Copyright © 2023 Biotech Networks, LLC
